IHT Wealth Management’s Corcept Therapeutics CORT Stock Holding History

IHT Wealth Management’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-25	Closed	–	–	1698
2017 Q4	$0	Buy	+25	New	+$453	﹤0.01%	1706

Other funds holding CORT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

IHT Wealth Management's CORT Position: Q1 2018 in Review

IHT Wealth Management sold out of Corcept Therapeutics (CORT) in Q1 2018, closing a stake of 25 shares.

IHT Wealth Management first reported a position in CORT in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 212 funds tracked by Wall St. Rank hold CORT as of Q1 2018.

IHT Wealth Management reported no remaining Corcept Therapeutics position as of Q1 2018 after selling out during the quarter.
IHT Wealth Management sold 25 Corcept Therapeutics shares in Q1 2018.
IHT Wealth Management first reported a position in Corcept Therapeutics in Q4 2017 and held it in 1 quarter.
IHT Wealth Management's Corcept Therapeutics position peaked at $0 in Q4 2017.
212 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2018.

Based on IHT Wealth Management's 13F filing for Q1 2018, filed 15 May 2018.